Download Brochure Button
×

Download Brochure

Fill in your details to get instant access

    We respect your privacy. No spam, ever.

    Conference Overview

    Unlocking the Future of Clinical Trials

    The 2nd Annual Clinical Trials Series 2026 serves as India’s premier platform to explore rapid market expansion and cutting-edge research innovations. Join global industry leaders to bridge the gap between regulatory intent and real-world execution through patient-centric trial design.

    Decentralised Trials (DCTs)

    Evaluate the transition toward remote trial models while balancing innovation, cost-efficiency, and patient access.

    Regulatory Reforms

    Discuss the latest updates on ICH GCP E6(R3) guidelines and streamlined approval pathways in the Asia-Pacific region.

    Technology and AI

    Discover how artificial intelligence and digital tools are transforming trial design, data analysis, and success rates.

    Inspection Readiness

    Learn to build robust compliance frameworks and risk monitoring strategies to meet post-pandemic regulatory expectations.

    Patient Centricity

    Focus on integrating safety, trust, and prioritized patient needs into every stage of the clinical research ecosystem.

    Real-World Evidence (RWE)

    Learn how to harness RWD to answer critical questions and improve structured benefit-risk assessments.

    Download Brochure

    Bridging Innovation & Integrity: Shaping the Future of Patient-Centric Clinical Trials

    India’s clinical trial market is expanding rapidly, valued at up to USD 2.1 billion in 2025 and projected to reach USD 4.3 billion by 2033. As a premier global research hub, India is leveraging a diverse patient population and regulatory streamlining to drive an 8-9% CAGR. The 2nd Annual Clinical Trials Series 2026 serves as a vital platform for professionals to explore future advancements, from decentralized trials to AI-driven designs. By fostering collaboration between industry leaders, academia, and regulatory bodies, the summit addresses real-world challenges in trial execution. Attendees will gain exclusive insights into the evolving healthcare outsourcing landscape and emerging patient-centric innovations.

    0+

    Speakers

    0+

    Attendees

    0+

    Hrs NETWORKING

    0+

    SESSIONS

    OUR ATTENDEES
    Trusted by Industry Leaders Worldwide

    REGISTER ATTEND LEARN NETWORK SUCCEED

    5 reasons to attend the events

    We Simplify Planning, Boost Engagement, And Create Unforgettable Experiences.

    Expert Insights

    Learn from world-class leaders and high-level speakers across the clinical research ecosystem. Gain specialized knowledge on the latest business models and strategic industry developments.

    Strategic Networking

    Enjoy dedicated networking time to connect with decision-makers and global peers. Meet leading international vendors showcasing future products in the co-located exhibition.

    Market Intelligence

    Explore the rapidly expanding Indian clinical trial market, projected to reach up to USD 4.3 billion by 2033. Understand the growth drivers, including digital adoption and regulatory streamlining in the Asia-Pacific region.

    Regulatory Mastery

    Engage in deep dives regarding ICH GCP E6(R3) implementation and evolving regulatory reforms in India. Access practical strategies for maintaining inspection readiness and a culture of compliance.

    Innovation Spotlight

    Discover how AI and emerging technologies are transforming trial design and execution. Stay updated on cutting-edge trends like Decentralised Clinical Trials (DCTs) and Real-World Evidence (RWE).

    Meet Our Expert Speakers

    Ramesh Jagannathan

    Bharat Serums and Vaccines

    SHUBHADEEP SINHA

    Hetero Labs

    Pratik Shah

    Bharat Serums and Vaccines

    SURAJ RAVINDRAN

    GSK

    Vijay Parthasarathy

    Novo Nordisk

    Krishnendu Sengupta

    AstraZeneca

    Vaibhav Salvi

    Sanofi

    MOHAMMED IQBAL

    GSK

    ARPIT SHAH

    Worldwide Clinical Trials

    Nisin C R

    Novartis

    KHALEEL AHMAD

    Bristol Myers Squibb

    MANSOOR NALAKATH

    Eli Lilly and Company

    Vishika Hegde

    GSK

    Souvik Chatterjee

    Novartis

    MILIND ANTANI

    Nishith Desai Associates

    Jegan Jayabalan

    Recipharm

    Hitendra Nath Pandey

    Eli Lilly and Company

    ANIL BHOJWANI

    GSK

    UME ASMA

    Pfizer

    Renuka Neogi

    Sun Pharma

    Aswin Kumar

    Viatris

    Sajjad Patil

    Biocon Biologics

    Neelakant Krishnan

    Sun Pharma

    Rahul Rathod

    AbbVie (Former)

    Tanveer Mubashir

    Takeda

    Prashant Mehrotra

    Bharat Serums and Vaccines

    KAVITA LAMROR

    Maxis Clinical (Former)

    OUR EVENT SCHEDULE

    08:30 – Coffee & Registration – An opportunity to meet and to network with your conference colleagues.

    09:20 – Welcome Address & Opening Remarks

    Speaker TBC
    Clinevo Technologies

    DIVAKAR KOLLI

    Cipla

    CLINICAL RESEARCH

    09:30 – The Evolving Landscape of Clinical Research: Challenges to Opportunities

    • Balancing data privacy, global regulations, and the rise of decentralized trials.
    • Tackling data complexity while advancing trial innovation and adaptive designs.
    • Breaking down barriers to diversity, inclusion, and digital accessibility in participation.
    • Navigating high costs, long timelines, and funding pressures impacting trial efficiency.
    • Leveraging India’s growing potential as a clinical research hub.
    • Strengthening vendor partnerships and optimizing patient engagement through tech-forward strategies.

    SARVESH SINGH

    Telangana Lifesciences

    WORKING TOGETHER

    10:00 – DISCUSSION WITH EXPERTS: Working Together - Strengthening Clinical Trial Ecosystems: Aligning Sponsors, Sites, CROs, and Patients. Next-Generation Trial Collaboration

    Moderator

    ASWIN KUMAR

    Viatris

    Panellists

    KHALEEL AHMAD

    Bristol Myers Squibb

    NISIN C.R

    Novartis

    JEGAN JAYABALAN

    Recipharm

    TANVEER MUBASHIR

    Takeda

    SAJJAD PATIL

    Biocon Biologics

    10:50 – Morning Coffee/Tea & Discussion

    (DCTs)

    11:20 – KEYNOTE PANEL DISCUSSION: “Decentralized & Hybrid Clinical Trials: Advancing Patient-Centric, Scalable, and Sustainable Research” - From Sites to Screens

    Moderator

    SHUBHADEEP SINHA

    Hetero Group

    Panellists

    RAMESH JAGANNATHAN

    Bharat Serums and Vaccines

    SURAJ RAVINDRAN

    GSK

    KRISHNENDU SENGUPTA

    AstraZeneca

    MANSOOR NALAKATH

    Eli Lilly and Company

    NEELAKANT KRISHNAN

    Sun Pharma

    12:10 – Topic TBC

    For sponsorship opportunities please contact   

    info.uk@virtueinsight.com

    JASON BRYANT

    CSL Behring

     12:40 –Networking luncheon

    REGULATORY

    13:30 – DISCUSSION WITH EXPERTS: Regulatory Excellence in Outsourced Clinical Trials: Ensuring Compliance, Innovation & Efficiency in a Global Landscape

    Moderator

    MILIND ANTANI

    Nishith Desai Associates

    Panellists

    VIJAY PARTHASARATHY

    Novo Nordisk

    SOUVIK CHATTE

    Bristol Myers Squibb

    ARPIT SHAH

    Worldwide Clinical Trials

    VISHIKA HEGDE

    GSK

    OUTSOURCING / PARTNERSHIP

    14:30 - Optimizing Clinical Trials Outsourcing: Finding the balance between quality, control & speed

    • Embracing specialized outsourcing to boost efficiency, global reach, and market agility.
    • Weighing risks and rewards of third-party production on quality and compliance.
    • Leveraging AI and emerging tech to enhance outsourcing effectiveness and transparency.
    • Rethinking in-house limitations vs. CRO expertise in managing complex trials.
    • Building smarter CRO partnerships for flexibility, accuracy, and faster outcomes.
    • Adapting to evolving sourcing models, rising costs, and competitive pressures.
    • Upskilling the workforce to align with tech-driven outsourcing strategies.

    SHUBHADEEP SINHA

    Hetero Labs

    15:00 – Afternoon Tea/Coffee

    IMPACT OF TECHNOLOGY

    15:30 – DISCUSSION WITH EXPERTS: Technology Driven & Next-Gen Clinical Trials: Leveraging AI, RWD & Digital Tools for Smarter Research

    Moderator

    KAVITA LAMROR

    Maxis Clinical

    Panellists

    PRATIK SHAH

    Bharat Serums and Vaccines

    MOHAMMED IQBAL

    GSK

    HITENDRA NATH PANDEY

    Eli Lilly and Company

    PRANAV SIKKA

    Novartis

    SHRADDHA BHANGE

    Sandoz

    CHALLENGES & OPPORTUNITIES

    16:20 – DISCUSSION WITH EXPERTS: Clinical Trials at the Crossroads: Overcoming Today’s Challenges, Shaping Tomorrow’s Success. What’s our way forward?

    Moderator

    VIJAY KRISHNAN

    Opella

    Panellists

    VAIBHAV SALVI

    Sanofi

    UME ASMA

    Pfizer

    ANIL BHOJWANI

    GSK

    RENUKA NEOGI

    Sun Pharma

    RAHUL RATHOD

    AbbVie

    PRASHANT MEHROTRA

    Bharat Serums and Vaccines

    17:00 – Closing Remarks & End of conference

    14:50 - Re-imagining Dossier Authoring: From Manual Compilation to AI-Assisted Authoring and Lifecycle Management

    • AI-driven automation in dossier creation: Transition from time-consuming manual compilation to intelligent automation where AI tools structure, draft, and validate regulatory dossiers using pre-designed templates as per ICH guidelines and real-time data processing.
    • Enhanced compliance and efficiency: AI-assisted authoring ensures alignment with global regulatory standards (e.g., EMA, USFDA, CDSCO) by auto-updating changes in guidance and improving accuracy, traceability, and submission timelines.
    • Lifecycle intelligence and version management: Integrating AI into the dossier lifecycle enables continuous monitoring, smart version control, and predictive updates across product changes, fostering a fully connected regulatory ecosystem.

    MANASA KASIVAJJULA

    CEO and Co-Founder

    DeepForrest.ai (A CtrlS Company)

    Our Partners

    We sincerely thank the following organizations and individuals for generously contributing their time, financial support, ideas, and dedication toward the successful conduct of the 17th Annual Clinical Trials Summit 2026

    Principal Partner

    Exhibitors

    Event Venue

    Sterling's Mac Hotel
    Bengaluru
    India
    080 4249 4949

    Get Involved

    Networking App

    Kindly Note!

    Access to view and connect with other attendees through our mobile app will be enabled closer to the conference date.

    Pricing Details

    Exclusive Offer 3 for 2 for Limited Seats Only

    Super Early Bird Price

    PRICE — INR 11,000 + GST (18%) PER DELEGATE (Valid till 31 July 2026)

    You can simply email or call and book your conference delegate seats on:

    TEL: + 91 44 4210 8101 (or) Email — info@virtueinsight.com

    Accommodation

    We have secured special room rates for our conference participants who wish to stay at “Sterling's Mac Hotel” during the conference dates, which is conveniently located next to the conference venue at the World Trade Centre.

    Once you confirm your participation, our operations team will share the room reservation details along with the booking deadline and the special rates we’ve arranged.

    Event Testimonials

    United Kingdom

    Block 3, 86 Coombe Road
    Croydon CR0 5RA
    London, UK

    Asia

    Plot No – 07 – 2nd Floor
    Ekambaram Industrial Estate
    Alapakkam, Porur Chennai,
    India – 600 116

    Download App

    Follow Us